MedTrace Logo

Acupuncture in the Treatment of Gulf War Illness

NCT01305811 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2015-06-15

Study results available
· View outcomes & findings →

Summary

This unblinded Phase II clinical trial tested the effects of individualized acupuncture treatments offered in extant acupuncture practices in the community; practitioners had at least 5 years of experience plus additional training provided by the study. Veterans with diagnosed symptoms of Gulf War Illness were randomized to either six months of biweekly acupuncture treatments (group 1, n=52) or 2 months of waitlist followed by weekly acupuncture treatments (group 2, n=52). Measurements were taken at baseline, 2, 4 and 6 months. The primary outcome is the SF-36 physical component scale score (SF-36P).

Conditions

  • Persian Gulf Syndrome

Interventions

DEVICE

Acupuncture

Sterile insertive needles are applied by licensed, experienced practitioners.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • New England School of Acupuncture

    lead OTHER

Principal Investigators

  • Lisa A Conboy, ScD · New England School of Acupuncture

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01305811 on ClinicalTrials.gov